Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Inventory Average (2016 - 2026)

Aytu Biopharma has reported Inventory Average over the past 11 years, most recently at $9.4 million for Q4 2025.

  • Quarterly Inventory Average fell 17.82% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.4 million through Dec 2025, down 17.82% year-over-year, with the annual reading at $11.8 million for FY2025, 2.32% down from the prior year.
  • Inventory Average was $9.4 million for Q4 2025 at Aytu Biopharma, down from $10.8 million in the prior quarter.
  • Over five years, Inventory Average peaked at $16.4 million in Q4 2021 and troughed at $9.4 million in Q4 2025.
  • The 5-year median for Inventory Average is $12.6 million (2023), against an average of $12.7 million.
  • Year-over-year, Inventory Average surged 82.11% in 2021 and then decreased 27.36% in 2022.
  • A 5-year view of Inventory Average shows it stood at $16.4 million in 2021, then fell by 21.45% to $12.9 million in 2022, then rose by 0.57% to $13.0 million in 2023, then decreased by 12.1% to $11.4 million in 2024, then fell by 17.82% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Inventory Average are $9.4 million (Q4 2025), $10.8 million (Q3 2025), and $11.2 million (Q2 2025).